1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,447 | 0,453 | 06.02. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.01. | Proposals of the Shareholders' Nomination Board of Bioretec Ltd to the Annual General Meeting 2026 | 274 | PR Newswire | Bioretec Ltd Company announcement 30 January 2026 at 1.45 p.m EETTAMPERE, Finland, Jan. 30, 2026 /PRNewswire/ -- The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has resolved... ► Artikel lesen | |
| 16.01. | Bioretec: CMS Transitional Pass-Through Payment (TPT) description for HCPCS code C1741 has been revised | 754 | PR Newswire | TAMPERE, Finland, Jan. 16, 2026 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, was granted Transitional Pass-Through Payment (TPT) status by the U.S. Centers for... ► Artikel lesen | |
| 15.01. | Bioretec beruft Tuukka Paavola zum neuen Finanzvorstand | 13 | Investing.com Deutsch | ||
| 15.01. | Bioretec names Tuukka Paavola as new CFO | 3 | Investing.com | ||
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 15.01. | Tuukka Paavola appointed as Chief Financial Officer of Bioretec | 252 | PR Newswire | Bioretec Ltd Company announcement 15 January 2026 at 5:30 p.m. EETTAMPERE, Finland, Jan. 15, 2026 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Tuukka... ► Artikel lesen | |
| 22.12.25 | Bioretec Ltd's schedule for financial reporting and Annual General Meeting in 2026 | 336 | PR Newswire | Bioretec Ltd Company announcement 22 December 2025 at 5:30 p.m. EETTAMPERE, Finland, Dec. 22, 2025 /PRNewswire/ -- In 2025, Bioretec will publish the following financial reports:
financial... ► Artikel lesen | |
| 16.12.25 | Bioretec Board Approves Updated Strategy, Financial Targets For 2026-2028 Period | 8 | RTTNews | ||
| 16.12.25 | Inside information: Bioretec updates its strategy for 2026-2028 and provides new financial targets | 205 | PR Newswire | Bioretec Ltd Inside information 16 December 2025 at 8:45 a.m. EETTAMPERE, Finland, Dec. 16, 2025 /PRNewswire/ -- As announced in September, Bioretec Ltd ("Bioretec" or the "Company") has... ► Artikel lesen | |
| 15.12.25 | Bioretec Secures FDA Breakthrough Device Designation For RemeOs DrillPin | 5 | RTTNews | ||
| 14.12.25 | Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs DrillPin | 508 | PR Newswire | Bioretec Ltd Inside information 14 December 2025 at 5:45 p.m. EETTAMPERE, Finland, Dec. 14, 2025 /PRNewswire/ -- Bioretec Oy ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic... ► Artikel lesen | |
| 04.12.25 | Change negotiations completed at Bioretec | 332 | PR Newswire | Bioretec Ltd Press release 4 December 2025 at 12.00 p.m. EETTAMPERE, Finland, Dec. 4, 2025 /PRNewswire/ -- On November 12, 2025, Bioretec announced the start of statutory change negotiations... ► Artikel lesen | |
| 13.11.25 | Bioretec Oy Q3 Loss Widens | 2 | RTTNews | ||
| 13.11.25 | Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design | 518 | PR Newswire | Bioretec Ltd Company release 13 November 2025 at 8.30 a.m. EET
TAMPERE, Finland, Nov. 13, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for... ► Artikel lesen | |
| 12.11.25 | Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness | 286 | PR Newswire | Bioretec Ltd Inside information 12 November 2025 at 12.30 p.m. EET
TAMPERE, Finland, Nov. 12, 2025 /PRNewswire/ -- Bioretec Ltd is initiating change negotiations in accordance... ► Artikel lesen | |
| 31.10.25 | Bioretec Ltd.: Half-year report 2025 - Correction | 524 | PR Newswire | Bioretec Ltd Company release 31 October 2025 at 8.30 a.m. EET
TAMPERE, Finland, Oct. 31, 2025 /PRNewswire/ -- Bioretec announced on 27 October 2025 that it will adjust and restate... ► Artikel lesen | |
| 27.10.25 | Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025 | 326 | PR Newswire | Bioretec Ltd Inside information 27 October 2025 at 9.14 p.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| 27.10.25 | Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets | 296 | PR Newswire | Bioretec Ltd Inside information 26 October 2025 at 10.00 a.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| 01.10.25 | Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US | 264 | PR Newswire | TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted... ► Artikel lesen | |
| 16.09.25 | Composition of Bioretec's Shareholders' Nomination Board | 3 | Cision News | ||
| 15.09.25 | Bioretec Oy: Inside information: Anne-Mari Matikainen appointed as Interim Chief Financial Officer of Bioretec; CFO Johanna Salko to depart before year-end | 191 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 15 September 2025 at 5.30 p.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Anne-Mari Matikainen as Interim Chief Financial Officer, effective... ► Artikel lesen |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,440 | +1,65 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 24 Euro auf "Buy" belassen. Die vorläufigen Zahlen für 2025 hätten beim Umsatz und... ► Artikel lesen | |
| DRAEGERWERK | 86,30 | -0,46 % | DAX wartet auf Fed - Airbus, Bayer, Drägerwerk, Infineon, SUSS Microtec, Wacker Chemie im ... | Am deutschen Aktienmarkt herrscht zu Handelsbeginn wenig Bewegung - die Anleger warten gespannt auf die nächste Notenbankentscheidung in den USA heute Abend. Am Vortag scheiterte der DAX zudem an der... ► Artikel lesen | |
| INTUITIVE SURGICAL | 413,35 | +0,02 % | INTUITIVE SURGICAL INC - 10-K, Annual Report | ||
| INSULET | 204,70 | +0,05 % | INSULET CORP - 8-K, Current Report | ||
| CYTOSORBENTS | 0,575 | -0,86 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| REVENIO GROUP | 18,720 | -3,31 % | Revenio Group Corporation: Change in the Revenio Leadership Team: Kate Taylor to step down | Revenio Group Corporation | Stock Exchange Release | January 15, 2026 at 14:30:00 EET
Leadership team member Dr. Kate Taylor (Vice President, Strategy and Business Development), will step down from... ► Artikel lesen | |
| OPTOMED | 3,725 | -3,87 % | OPTOMED OYJ: Optomed's Financial Statements Bulletin will be published on 10 February 2026 | ||
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Der Aktienkurs der Münchner spiegle die mittelfristigen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | DAX-Check LIVE: Fresenius Medical Care, Nordex, Puma, Sartorius Vz., Schaeffler, Siltronic im Fokus | Ein kurzzeitiger Ausverkauf bei Gold und Silber hat den DAX zum Wochenstart zunächst belastet. Die Unsicherheit beruhigte sich jedoch im Tagesverlauf, auch unterstützt durch eine Erholung an den US-Märkten.... ► Artikel lesen | |
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |
BIORETEC OY gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,446 Euro und damit -0,45 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.